Pimavanserin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 376 publications
Symptomatic treatment for Alzheimer disease: current evidence and future directions.
Journal: Nature reviews. Neurology
Published: August 10, 2026
Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.
Journal: Journal of psychopharmacology (Oxford, England)
Published: June 25, 2026
Dextromethorphan/bupropion (Auvelity) for agitation in Alzheimer's dementia.
Journal: The Medical letter on drugs and therapeutics
Published: June 15, 2026
Dually Acting Ligands Targeting Serotonin Receptors: Implications in CNS Disorders.
Journal: Journal of medicinal chemistry
Published: April 27, 2026
An Open-Label Study Investigating the 5-HT2A Receptor Occupancy of Remlifanserin (ACP-204) With the PET Radioligand [18F]Altanserin in Healthy Male Participants.
Journal: Clinical pharmacology in drug development
Published: April 03, 2026
Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: February 13, 2026
Adjunctive pimavanserin in schizophrenia: A systematic review and meta-analysis with a focus on negative-symptom programmes.
Journal: Asian journal of psychiatry
Published: January 29, 2026
Expert group recommendations on the use of antipsychotic drugs in patients with somatic diseases. Part II: renal failure, liver failure, neurological diseases.
Journal: Psychiatria polska
Published: January 23, 2026
Expert group recommendations on the use of antipsychotic drugs in patients with somatic diseases. Part I: (metabolic syndrome, cardiovascular diseases).
Journal: Psychiatria polska
Published: January 23, 2026
Discovery of novel SSRIs for a combination-treatment with pimavanserin.
Journal: Bioorganic & medicinal chemistry letters
Published: January 12, 2026
Prefrontal 5-HT 2A receptors directly contribute to tic ontogeny: translational evidence.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Last Updated: 09/26/2026